Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 1

Neurocutaneous Syndromes and Epilepsy

Nörokutanöz Sendromlar ve Epilepsi

Journal
Epilepsi
Pages
12–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Attention is drawn to the prevalence of neurocutaneous syndrome in epileptic adults, with seizure frequency depending on syndrome type.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Neurocutaneous syndromes are genetic diseases that affect the nervous system and the skin.
📊
Key Findings & Data:In the present study, data of 29 patients from 5 centers were analyzed in an effort to draw attention to the disease group.
💡
Conclusion & Impact:Conclusion: Attention is drawn to the prevalence of neurocutaneous syndrome in epileptic adults, with seizure frequency depending on syndrome type.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Neurocutaneous syndromes are genetic diseases that affect the nervous system and the skin. Epileptic seizures are seen with variable frequency. In the present study, data of 29 patients from 5 centers were analyzed in an effort to draw attention to the disease group. Methods: Data of 29 patients diagnosed with neurocutaneous syndrome were retrospectively evaluated. Results: Study population was composed of 15 women (51.7%) and 14 men (48.3%), with a mean age of 31 (72±2.16). Ten patients (34.5%) were diagnosed with tuberous sclerosis, 9 (31%) with Sturge–Weber syndrome, 3 (10.3%) with neurofibromatosis type 1, 3 (10.3%) with neurofibromatosis type 2, 1 (3.4%) with neurocutaneous melanosis, 1 (3.4%) with hypomelanosis of Ito, 1 (3.4%) with probable Sturge–Weber syndrome, and 1 patient was diagnosed with unclassified neurocutaneous syndrome. One patient did not receive antiepileptic treatment, 9 (31%) received monotherapy, and 19 (65.5%) received polytherapy. Carbamazepine was the most commonly used medication. Conclusion: Attention is drawn to the prevalence of neurocutaneous syndrome in epileptic adults, with seizure frequency depending on syndrome type.

Özet

Amaç: Nörokutanöz sendromlar; hem sinir sistemini hem de deriyi tutan bir grup genetik hastalıktır. Bu hasta grubunda değişen sıklıkta epileptik nöbetler görülmektedir. Bu çalışmayla beş farklı merkezden toplanan 29 hastanın incelenmesi ve bu hastalık grubuna dikkat edilmesi amaçlanmıştır. Gereç ve Yöntem: Beş farklı merkezde izlenen nörokutanöz sendromlu 29 epilepsi hastası geriye dönük olarak değerlendirilmiştir. Bulgular: Çalışmaya 15 kadın hasta (%51.7) ve 14 erkek hasta (%48.3) olmak üzere toplam 29 hasta alındı. Hastaların yaş ortalaması 31.72±2.16 yıldı. Hastaların 10’u (%34.5) tuberoz skleroz, dokuzu (%31) Sturge-Weber sendromu, üçü (%10.3) nörofibromatozis tip-1, biri (%10.3) nörofibromatozis tip-2, biri (%3.4) nörokutanöz melanozis, biri (%3.4) olası ito melanozisi, biri (%3.4) olası Sturge-Weber sendromu, ve biri (%3.4) de tanımlanamayan nörokutanöz sendromlu hastalardı. Hastalardan sadece biri antiepileptik ilaç tedavisi almazken, dokuz hasta (%31) monoterapi, 19 hasta (%65.5) politerapi altındaydı. En sık kullanılan antiepileptik ilaç kabamazepin idi. Sonuç: Nörokutanöz sendromlu epilepsi hastalarının erişkin dönemde de görülebileceğine dikkat çekmek ve sendrom tiplerine bağlı olarak değişen sıklıklarda epileptik nöbetlerin görülebileceğini vurgulamak istedik.

🔖

Cite This Article

ERDAL, A., DEMİR, A. B., MİDİ, İ., GÖMCELİ, Y. B., KUTLU, G., YENİ, S. N., BORA, İ. (2016). Neurocutaneous Syndromes and Epilepsy. Epilepsi, Cilt: 22 - Sayı: 1, 12–16. https://ajindex.com/articles/158364

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Anlar B. Sinir sisteminin gelişimsel hastalıkları. Emre A, Çeviri Editörü. Adam’s and Victor’s principles of neurology. 9th ed. An- kara: Güneş Kitabevleri 2011. s. 960–1010.
  2. Thiele EA, Granata T, Matricardi S, Chugani HT. Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis. Epilepsia 2014;55 Suppl 3:29–33.
  3. Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015;36(7):1173–80.
  4. Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia 2013;54(10):1810–4.
  5. DiFrancesco JC, Sestini R, Cossu F, Bolognesi M, Sala E, Mariani S, et al. Novel neurofibromatosis type 2 mutation presenting with status epilepticus. Epileptic Disord 2014;16(1):132–7. Józwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000;15(10):652–9.
  6. Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996;38(2):146–55.
  7. Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010;51(7):1236–41.
  8. Saxena A, Sampson JR. Epilepsy in Tuberous Sclerosis: Phenotypes, mechanisms, and treatments. Semin Neurol 2015;35(3):269–76.
  9. Saltık S, Karatoprak EY, Taşel B. Characteristics and the clinical prognosis of epilepsy in patients with a diagnosis of tuberous sclerosis complex. Türk Ped Arş 2013;123–30.
  10. Sudarsanam A, Ardern-Holmes SL. Sturge-Weber syndrome: from the past to the present. Eur J Paediatr Neurol 2014;18(3):257–66.
  11. El Beltagi AH, Fahmy H, Nasef N, Norbash A, Abdalla D. Stable neurocutaneous melanosis in a ten-year-old boy with controlled partial-complex seizures. A case report. Neuroradiol J 2012;25(2):206–11.